The efficacy and safety analysis of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma (vol 13, 956982, 2022)
FRONTIERS IN IMMUNOLOGY（2023）
关键词
pulmonary sarcomatoid carcinoma, immune checkpoint inhibitors, immunotherapy, anlotinib, camrelizumab, tislelizumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要